What do CD4 (cluster of differentiation 4) and CD3 (cluster of differentiation 3) T cell levels look like in a patient with Systemic Lupus Erythematosus (SLE)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CD4 and CD3 T Cell Profiles in Systemic Lupus Erythematosus

Overview of T Cell Abnormalities in SLE

In SLE patients, CD3+ T cells show multiple phenotypic abnormalities, with approximately 45% of patients demonstrating markedly depressed CD4+ T cell levels and abnormal CD4/CD8 ratios, while CD8+ T cell percentages typically remain normal. 1

CD4+ T Cell Patterns

Quantitative Changes

  • Two distinct patient subgroups exist: 55% of SLE patients (Group A) maintain normal CD4+ T cell levels with normal CD4/CD8 ratios, while 45% (Group B) have significantly depressed CD4+ cells with low CD4/CD8 ratios 1

  • CD4+ T cells in SLE show a shift from naïve to memory phenotypes, with higher frequencies of memory T cells and lower frequencies of naïve T cells compared to healthy controls 2

CD4+ T Cell Subset Abnormalities

  • CD4+CD28- T cells are expanded in SLE patients and show an imbalance compared to CD4+CD28+ cells 2

    • These expanded CD4+CD28- T cells fail to decrease after treatment in patients with impaired renal responses 2
    • A negative correlation exists between CD4+CD28- T cells and regulatory T (Treg) cells 2
  • Regulatory T cells (CD4+CD25+Foxp3+ Treg) are significantly decreased in SLE patients, with lower numbers correlating to higher SLEDAI scores (rs = -0.75, p < 0.0001) 3

  • T follicular helper (Tfh) cells and CD4+CXCR5-PD1+ T cells are expanded and associate with disease activity 2

  • Th1 cells and Treg cells are decreased, while Th2, Th17, and Tfh17 cells are increased 2

CD3+ T Cell Patterns

Overall CD3+ Population

  • CD3+ T cells in SLE demonstrate broad phenotypic anomalies across multiple subsets compared to healthy controls 2

  • CD3+CD4-CD8- (double negative) T cells are expanded in SLE patients, particularly the TCRαβ+ subpopulation 4

    • These double negative T cells express increased activation markers 4
    • A higher percentage constitutively contain IL-4 compared to healthy controls 4

CD8+ T Cell Patterns

  • CD8+ T cell percentages remain normal in virtually all SLE patients 1

  • CD8+HLA-DR+ T cells and CD8+CD38+HLA-DR+ T cells are increased, suggesting impaired cytotoxic capacity 2

    • CD8+CD38+HLA-DR+ T cells closely associate with disease activity, autoantibody titers, and renal prognosis 2

Functional Implications

Suppressor Function Defects

  • In Group B patients (low CD4+ counts), there is defective CD4 cell-mediated suppression that is concentration-dependent 1

  • In Group A patients (normal CD4+ counts), CD4 cell-mediated suppression is normal, but CD8+ suppressor cell function is defective 1

Clinical Monitoring Considerations

  • Severe lymphopenia (<500 cells/mm³) requires continuous assessment as it increases infection risk 5

  • The European League Against Rheumatism recommends monitoring lymphocyte counts alongside other immunological parameters during follow-up visits, particularly in patients on immunosuppressive therapy 5

  • Cellular populations (CD8+, CD3+/DR+, CD4+, CD19+, CD56+) remain practically unchanged before and after anti-pneumococcal vaccination, indicating vaccine safety 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.